DNA X, Inc.

DNA X, Inc.SONMEarnings & Financial Report

Nasdaq · Consumer Discretionary · Telephone & Telegraph Apparatus

SONM Q3 FY2025 Key Financial Metrics

Revenue

$16.2M

Gross Profit

$1.8M

Operating Profit

$-4.0M

Net Profit

$-4.8M

Gross Margin

11.2%

Operating Margin

-24.5%

Net Margin

-29.3%

YoY Growth

7.9%

EPS

$-4.83

DNA X, Inc. Q3 FY2025 Financial Summary

DNA X, Inc. reported revenue of $16.2M (up 7.9% YoY) for Q3 FY2025, with a net profit of $-4.8M (down 89.2% YoY) (-29.3% margin). Cost of goods sold was $14.4M, operating expenses totaled $5.8M.

Key Financial Metrics

Total Revenue$16.2M
Net Profit$-4.8M
Gross Margin11.2%
Operating Margin-24.5%
Report PeriodQ3 FY2025

DNA X, Inc. Annual Revenue by Year

DNA X, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $50.9M).

YearAnnual Revenue
2024$50.9Mvs 2023
2023$93.6Mvs 2022
2022$69.8M

DNA X, Inc. Quarterly Revenue & Net Profit History

DNA X, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q3 FY2025$16.2M+7.9%$-4.8M-29.3%
Q2 FY2025$11.2M-2.8%$-7.5M-66.8%
Q1 FY2025$16.7M+83.4%$458.0K2.7%
Q4 FY2024$15.3M+13.6%$-21.6M-141.6%
Q3 FY2024$15.0M-45.5%$-2.5M-16.7%
Q2 FY2024$11.5M-57.1%$-6.6M-57.5%
Q1 FY2024$9.1M-64.7%$-2.9M-31.9%
Q4 FY2023$13.4M-44.3%$-1.4M-10.1%

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$13.4M$9.1M$11.5M$15.0M$15.3M$16.7M$11.2M$16.2M
YoY Growth-44.3%-64.7%-57.1%-45.5%13.6%83.4%-2.8%7.9%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$56.0M$42.4M$45.9M$49.1M$39.7M$36.0M$36.1M$40.2M
Liabilities$33.7M$22.5M$28.4M$33.8M$45.4M$37.0M$37.4M$40.9M
Equity$22.4M$19.8M$17.5M$15.3M$-5.7M$-1.1M$-1.3M$-701000

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-351000$-168000$-3.4M$-417000$-4.5M$-9.6M$-4.9M$-7.0M